Essex Investment Management’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Essex Investment Management’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-62,860	Closed	-$1.28M	–	567
2018 Q3	$1.28M	Sell	62,860 -59,214	-49%	-$1.22M	0.15%	198
2018 Q2	$1.95M	Hold	122,074	–	–	0.24%	119
2018 Q1	$1.75M	Sell	122,074 -12,891	-10%	-$176K	0.23%	129
2017 Q4	$1.77M	Buy	+134,965	New	+$2.43M	0.23%	132

Other funds holding NITE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Essex Investment Management's NITE Position: Q4 2018 in Review

Essex Investment Management sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2018, closing a stake of 62,860 shares — an estimated $1.28M sold.

Essex Investment Management first reported a position in NITE in Q4 2017 and held it in 4 quarters. The position peaked at $1.95M in Q2 2018. 29 funds tracked by Wall St. Rank hold NITE as of Q4 2018.

Essex Investment Management reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Essex Investment Management sold 62,860 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2018, an estimated $1.28M.
Essex Investment Management first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q4 2017 and held it in 4 quarters.
Essex Investment Management's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.95M in Q2 2018.
29 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.